REG - Surgical Innovations - Directorate Change & Notice of Results

Surgical InnovationsAnnouncement

09/04/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240409:nRSI7414Ja&default-theme=true

RNS Number : 7414J  Surgical Innovations Group PLC  09 April 2024

Surgical Innovations Group plc

("Surgical Innovations", the "Company", or the "Group")

 

Directorate Change & Notice of Results

Investor presentation

 

Surgical Innovations Group plc (AIM: SUN), the designer, manufacturer and
distributor of innovative technology for minimally invasive surgery, announces
that further to the 19 December 2023
(https://www.londonstockexchange.com/news-article/SUN/directorate-change/16257468)
announcement regarding Charmaine Day's intention to step down from her role as
Chief Financial Officer ("CFO"), the Company confirms that Charmaine has now
left the Group. Michael Roper, an interim financial consultant, has been
supporting the business since February 2024 and is now overseeing the finance
function.

 

Michael Roper is a highly experienced financial consultant who has served as
an interim CFO for a number of organisations, including others in the medtech
sector. Michael will remain in place to facilitate an orderly transition
process once a permanent CFO is appointed. The process to recruit a new CFO
continues and a further announcement will be made in due course.

 

Notice of results & investor briefing

Surgical Innovations will release its audited results for the year ended 31
December 2023 on Thursday 18 April 2024.

 

David Marsh, Chief Executive Officer, and Jonathan Glenn, Chairman, will
provide a live presentation relating to the final results via the Investor
Meet Company platform on 18 April 2024 at 11.00am GMT.

 

The presentation is open to all existing and potential shareholders. Questions
can be submitted pre-event via your Investor Meet Company dashboard up until
9:00 a.m. the day before the meeting or at any time during the live
presentation.

 

Investors can sign up to Investor Meet Company for free and add to
meet Surgical Innovations Group plc via:

https://www.investormeetcompany.com/surgical-innovations-group-plc/register-investor
(https://www.investormeetcompany.com/surgical-innovations-group-plc/register-investor)
. Investors who already follow Surgical Innovations Group plc on the
Investor Meet Company platform will automatically be invited.

 

For further information please contact:

 

 Surgical Innovations Group plc                       www sigroupplc com (http://www.sigroupplc.com/)
 David Marsh, CEO                                     Tel: 0113 230 7597

 Singer Capital Markets (Nominated Adviser & Broker)                                      Tel: 020 7496 3000
 Aubrey Powell / Oliver Platts

 Walbrook PR (Financial PR & Investor Relations)      Tel: 020 7933 8780 or si@walbrookpr.com (mailto:si@walbrookpr.com)
 Paul McManus / Charlotte Edgar /                     Mob: 07980 541 893 / 07884 664 686 /

 Alice Woodings                                       07407 804 654

 

About Surgical Innovations Group plc

The Group specialises in the design, manufacture, sale and distribution of
innovative, high quality medical products, primarily for use in minimally
invasive surgery. Our product and business development is guided and supported
by a key group of nationally and internationally renowned surgeons across the
spectrum of minimally invasive surgical activity.

 

We design and manufacture and source our branded port access systems, surgical
instruments and retraction devices which are sold directly in the UK home
market through our subsidiary, Elemental Healthcare, and exported widely
through a global network of trusted distribution partners. Many of our
products in this field are based on a "resposable" concept, in which the
products are part reusable, part disposable, offering a high quality and
environmentally responsible solution at a cost that is competitive against
fully disposable alternatives.

 

Elemental also has exclusive UK distribution for a select group of specialist
products employed in laparoscopy, bariatric and metabolic surgery, hernia
repair and breast reconstruction.

 

In addition, we design and develop medical devices for carefully selected OEM
partners and have also collaborated with a major UK industrial partner to
provide precision engineering solutions to complex problems outside the
medical arena.

 

We aim for our brands to be recognised and respected by healthcare
professionals in all major geographical markets in which we operate and
provide by development, partnership or acquisition a broad portfolio of cost
effective, procedure specific surgical instruments and implantable devices
that offer reliable solutions to genuine clinical needs in the operating
theatre environment.

 

Further information

Further details of the Group's businesses and products are available on the
following websites:

www.sigroupplc.com (http://www.sigroupplc.com)

www.surginno.com (http://www.surginno.com)

www.elementalhealthcare.co.uk (http://www.elementalhealthcare.co.uk)

 

To receive regular updates by email, please contact si@walbrookpr.com
(mailto:si@walbrookpr.com)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAEAKLPEEFLEFA